Evolution of Nipah Virus Infection: Past, Present, and Future Considerations
Authors: Naomi Hauser, Alexis C. Gushiken, Shivakumar Narayanan, Shyam Kottilil, Joel V. Chua
Year: 2021
Journal: Tropical Medicine and Infectious Disease Review
DOI: 10.3390/tropicalmed6010024
Summary
This paper reviews the evolution of Nipah virus infection, its epidemiology, microbiology, and the therapeutic agents and vaccines in development.
Key Findings
- Nipah virus (NiV) is a zoonotic paramyxovirus with bat reservoir hosts
- Human infections with NiV have varying symptoms including fever, rapid neurological decline, and respiratory symptoms
- Nearly annual outbreaks have been described since 1998 with case fatality rates reaching greater than 90%
- The lack of effective therapy or vaccines makes NiV’s pandemic potential significant
Methodology
- Study Type: Review
Topics
Epidemiology, Clinical, Virology
Relevance
The paper reviews the current state of knowledge on Nipah virus and its high case fatality rate, highlighting the need for effective therapy and vaccines.
Source
View the entire paper: File:Tropicalmed-06-00024.pdf